These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 572279
21. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate. de Greef WJ, Dullaart J, Zeilmaker GH. J Endocrinol; 1976 Sep; 70(3):465-71. PubMed ID: 978105 [Abstract] [Full Text] [Related]
26. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate. Furuhjelm M, Carlström K. Acta Obstet Gynecol Scand; 1977 Sep; 56(4):351-61. PubMed ID: 602703 [Abstract] [Full Text] [Related]
27. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea. Jeppsson S, Johansson ED, Ljungberg O, Sjöberg NO. Acta Obstet Gynecol Scand; 1977 Sep; 56(1):43-8. PubMed ID: 842303 [Abstract] [Full Text] [Related]
28. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study. Gupta GN, Saxena BB, Landesman R, Ledger WJ. Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449 [Abstract] [Full Text] [Related]
30. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study. Lan PT, Aedo AR, Landgren BM, Johannisson E, Diczfalusy E. Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145 [Abstract] [Full Text] [Related]
31. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive. Ling WY, Johnston DW, Lea RH, Bent AE, Scott JZ, Toews MR. Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373 [Abstract] [Full Text] [Related]
32. The effect of ovarian steroid feedback upon radioimmunoreactive luteinizing hormone releasing hormone in the hypothalamus. Yanaihara T, Arai K, Kanazawa M, Okinaga S, Yanaihara N, Yanaihara C. Endocrinol Jpn; 1975 Dec; 22(6):525-30. PubMed ID: 782859 [Abstract] [Full Text] [Related]
35. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW, de la Peña A, Chenault CB, Cervantes A. Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928 [Abstract] [Full Text] [Related]
37. The role of follicle-stimulating hormone (FSH), in combination with luteinizing hormone (LH), in oestrogen-induced ovulation during the oestrous cycle in the rat. Plas-Roser S, Hassani M, Aron C. Acta Endocrinol (Copenh); 1977 May 01; 85(1):151-7. PubMed ID: 577073 [Abstract] [Full Text] [Related]
39. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Scott JZ, Kletzky OA, Brenner PF, Mishell DR. Fertil Steril; 1978 Aug 01; 30(2):141-5. PubMed ID: 98356 [Abstract] [Full Text] [Related]
40. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI, Winter JS, Faiman C. Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]